SLC38A2 and breast cancer: In the regulatory intersection between hypoxia and estrogenic signaling in BC, HIF-α activation is responsible for the downregulation of ER-α, and a switch in the regulation of sodium-coupled neutral amino acid transporter 2 is the key link [105, 208].